NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

Montserrat García‐Closas, Núria Malats, Debra T. Silverman, Mustafa Dosemeci, Manolis Kogevinas, David W. Hein, Adonina Tardón, Cònsol Serra, Alfredo Carrato, Reina García-Closas, Josep Lloreta, Gemma Castaño‐Vinyals, Meredith Yeager, Robert Welch, Stephen J. Chanock, Nilanjan Chatterjee, Sholom Wacholder, Claudine Samanic, Montserrat Torà, F. FERNÁNDEZ, Francisco X. Real, Nathaniel Rothman

The Lancet, 2005